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trol measures must be maintained and 
strengthened when sporadic cases are reported. 
Serological tests proven to be specific and reli­
able, such as E IA  and Western blot, could be use­
ful for investigating outbreaks of anthrax.
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Erysipelas-Like Skin Lesions 
Associated with Campylobacter 
jejuni Septicemia in Patients with 
Hypogammaglobulinemia
P.J.S.M. K erstens1*, H.P. E n dtz5, 
J.F.G.M. M eis2, W J .G . O y e n 3, 
R.J.I. K oop m an 4, P.J. van den B ro e k 6, 
J.W.M. van der M e e r1
Three cases are reported of hypogamma­
globulinémie males with recurrent Campylobac­
ter jejuni septicemia and erysipelas-like cellulitis 
without diarrhoea. In one patient Campylobacter 
jejuni grew from skin biopsy specimens. The find­
ings in another patient were strongly suggestive of 
osteomyelitis caused by Campylobacter jejuni. 
Since the susceptibility of hypogamma­
globulinémie patients to infection with Cam­
pylobacter jejuni is probably related to a lack of 
serum bactericidal activity against Campylobac­
ter jejuni due to lack of IgM, two patients in 
whom previous antimicrobial treatment failed 
were treated with plasma infusions. This regimen 
supplemented with imipenem resulted in cure of 
these relapsing infections. Campylobacter jejuni 
septicemia must be considered in hypogam­
maglobulinémie patients who present with peri­
odic fever and cellulitis.
Campylobacter jejuni subspecies jejuni (Cam ­
pylobacter jejuni) is a common cause of gastro­
enteritis (1), which is a self-limiting disease in 
most patients. However, Campylobacter jejuni 
can induce protracted diarrhoea (2, 3) and a 
prolonged carrier state (4, 5) in patients with 
hypogammaglobulinemia. R ecurren t septicemia 
due to Campylobacter jejuni has also been 
reported  in these patients (6-9). Until now only 
three cases of cellulitis during a period of sep­
ticemia with Campylobacter jejuni have been
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reported  (9, 10). A ttem pts  to isolate Cam­
pylobacter jejuni from the skin lesions were un­
successful (9).
We report on three cases of hypogam m a­
globulinémie males with recurrent Cam pylobac­
ter jejuni septicemia and erysipelas-like skin 
lesions.
Case Reports. Patient A, a 26-year-old male with 
X-linked hypogammaglobulinemia (Table 1) 
trea ted  with subcutaneous gammaglobulin sub­
stitution (50 mg/kg/week) (16), was admitted to 
hospital in August 1989 with fever and cellulitis of 
his right hand. A t the age of eight years he had 
developed lym phoedem a of his right hand for 
which no explanation was found. Over the past 
eight years he had suffered from recurrent skin 
lesions on his legs and right hand which were 
diagnosed as erysipelas. T here  was no clear 
response to trea tm ent with penicillin, flucloxacil- 
lin, ampicillin and cephalosporins.
During a camping trip shortly before admission 
he becam e febrile, started coughing and 
developed skin lesions on his right hand. On 
physical examination a tender, warm, ill-defined 
area of erythem a was seen on the back of the right 
hand. The chest x-ray showed a pulmonary in­
filtrate of the left lower lobe and sputum cultures 
grew Haemophilus influenzae. Administration of 
amoxicillin intravenously (4 x 1 g) and im m uno­
globulin G intravenously (6 g) resulted in rapid 
resolution of the pulmonary infection, but low 
grade fever persisted. The skin lesion extended 
and became m ore indurated (Figure 1). Because 
of the phlegmonous appearance, flucloxacillin 
was given without success. During antibiotic 
treatm ent, similar skin lesions appeared  on the 
pa tien t’s shins. In the m eantim e cultures of blood 
and stool specimens obtained at admission grew 
Campylobacter jejuni biotype I, serogroup L A U  
15. Biopsy specimens of affected skin were taken 
at the margin of the lesions on both the right hand 
and leg and processed directly for routine his- 
topathological examination, electron microscopy 
and culture. The cultures yielded Campylobacter  
jejuni biotype I, serogroup L A U  15. The strains 
isolated from the skin biopsies were susceptible 
to erythromycin (M IC < 1 mg/1), and those iso­
lated from stools were erythromycin resistant 
(M IC > 64 mg/1), whereas one of the two strains 
isolated from blood cultures was erythromycin 
susceptible, the o ther being resistant. All strains 
were resistant to ciprofloxacin (M IC > 16 mg/1). 
Histopathological studies, including silver-stain- 
ing, of the skin biopsies revealed no microor­
ganisms, but electron microscopy showed deep 
dermal inflammation with fibrin deposits and few 
bacteria. Erythromycin given orally in a dosage of 
2 g daily had no effect on either the fever or skin 
lesions. W hen intravenous gentamicin (5 mg/kg 
per day) was added to the regimen, both  fever and 
skin lesions rapidly disappeared. However, within 
two weeks after cessation of trea tm ent similar 
new skin lesions developed on the lower legs ac­
companied by low grade fever. Again stool and 
blood cultures grew Campylobacter jejuni of the 
same type; all strains were erythromycin and 
ciprofloxacin resistant. Cultures of skin biopsies 
remained sterile this time. On questioning and 
physical examination as well as on scintigraphy 
with indium-111 labelled human polyclonal non­
specific immunoglobulin G ( In - l l l - Ig G )  (17- 
19), no evidence of focal infection could be found. 
Treatm ent was given with imipenem ad­
ministered intravenously (4 x 500 mg) and plasma 
infusions (500 ml twice weekly) for two weeks. 
This regimen resulted in rapid resolution of skin 
lesions and fever. O ver a follow-up period of 
more than 2.5 years all stool cultures remained 
negative for Campylobacter jejuni, and neither 
skin lesions nor fever recurred.
Patient B, a 20-year-old hypogammaglobulinémie 
male (Table 1), experienced septicemia caused by 
Campylobacter jejuni biotype II, serogroup L A U  
5/15 in 1986, which relapsed after therapy with 
erythromycin but responded to ciprofloxacin. In 
N ovem ber 1989 he presented with an erysipelas­
like skin lesion on his left leg and fever, which did 
not respond to penicillin. Blood and stool cultures 
grew Campylobacter jejuni biotype II, serogroup 
L A U  5/15. Initially, a response to therapy with 
erythromycin was recorded, but shortly after ces­
sation of therapy relapse of the septicemia was 
seen. Skin lesions did not recur. A  six-week 
course of erythromycin was given and the patient 
recovered. M ore than one year later there  were 
no signs of Campylobacter jejuni infection having 
recurred.
Patient C, a 24-year-old male with X-linked 
hypogammaglobulinemia and chronic hepatitis 
with mild cirrhosis due to hepatitis B virus, suf­
fered recurrent bouts of fever over a period of 
several years. The fever episodes were originally 
attributed to respiratory tract infections. G am ­
maglobulin substitution was given by slow sub­
cutaneous infusions (16), resulting in satisfactory 
serum IgG concentrations (Table 1). In August 
1985 he presented with fever and an erysipelas­
like skin lesion on his left lower leg, which had not 
responded to amoxicillin and flucloxacillin.
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Table 1: Scrum immunoglobulin levels in three patients with hypogammaglobulinemia suffering from 
recurrent systemic Cam pylobacter jejuni infections before and during plasma infusion therapy.
Immunoglobulin levels (g/l)a
Patient A Patient B b Patient C
B efore treatment
IgA undetectable undetectable undetectable
IgG 4.18 4.60 4.60
IgM undetectable undetectable undetectable
During treatment
IgA 0.56 0.42
IgG 5.08 2.91
IgM 0.48 undetectable
a Normal values ± SD: IgA: 2.0 ± 0.6 g/1; IgG: 12.5 ± 2.1 g/1; IgM: 1.1 ± 0.4 g/1. 
b Patient B was not treated with imipenem and plasma infusions (see text).
Blood and stool cultures yielded Campylobacter  
jejuni biotype III, serogroup L A U  3, and trea t­
ment with erythromycin resulted in rapid resolu­
tion of both  fever and skin lesions. Stool cultures 
becam e negative for Campylobacter jejuni. One 
year later a similar skin lesion occurred on the 
pa tien t’s left lower leg. Although he was afebrile, 
blood cultures again yielded Campylobacter  
jejuni biotype III, serogroup L A U  3. The patient 
responded to oral erythromycin in a dosage of 2 g 
daily. In February 1990 he developed bouts of 
fever again, and somewhat looser stools than nor­
mal. The frequency of fever episodes increased 
from once weekly to every o ther day in March
1990. Fever was self-limiting and preceded by 
chills and rigors. During fever periods he also ex­
perienced pain in the lower legs, predominantly 
on the right side. No skin lesions occurred during 
this episode. Again blood and stool cultures grew 
Campylobacter jejuni biotype III, serogroup 
L A U  3 which was sensitive to erythromycin (MIC
< 0.5 mg/1), ciprofloxacin (M IC < 0.25 mg/1) and 
imipenem (M IC < 0.125 mg/1). A  seven-day 
course of erythromycin (2 g) given orally caused 
no relief of symptoms. O n physical examination 
no infectious focus was detected. However, In- 
111-IgG scintigraphy (17-19) showed increased 
uptake in the proximal tibia of the right leg and, to 
a lesser extent, in the proximal tibia of the left leg. 
O n technetium-99m-methylene diphosphonate 
(Tc-99m-MDP) scintigraphy areas of increased 
uptake were seen at the corresponding sites. 
N either plain radiographs nor CT scans of the 
lower legs showed abnormalities. No specimens 
were taken  for repeat cultures before treatm ent 
with intravenous imipenem (4 x 500 mg) and plas­
ma infusions (500 ml twice weekly) were started.
Within a few days after starting trea tm ent fever 
subsided and the pa t ien t’s condition improved. 
Pain in the lower legs did not recur. Plasma in­
fusions were given for four weeks, and imipenem 
was continued for a total of six weeks. A t the end 
of that time a follow-up I n - l l l - I g G  scintigraphy 
was negative. Treatm ent was subsequently 
stopped. Campylobacter jejuni infection did not 
recur, and repeated  cultures remained negative, 
despite the fact that the patient underw ent cancer 
chemotherapy 1.5 years later due to carcinoma of 
the colon with metastases. H e  died in D ecem ber 
1991. No autopsy was performed.
Methods. All strains isolated from blood were 
grown on blood agar plates containing sheep 
blood at 37 °C in an atm osphere of 5 % O 2 , 10 % 
C O 2 and 85 % N 2 . The strains from stool speci­
mens were isolated on blood agar plates with 
Skirrow’s supplem ent (11). The skin biopsy speci­
men was cut in half and both cut edges were 
streaked on blood and campylobacter agar plates; 
the rem ainder of the specimen was inoculated 
into brain heart infusion broth supplem ented 
with horse serum, V factor and defibrinated 
sheep blood. Cultures were incubated for two 
days at 37 °C and 42 °C under  microaerobic con­
ditions of 5 % O 2 , 10 % C O 2 and 85 % N 2 .
All Campylobacter jejuni cultures showed abun­
dant growth at 42 °C but not at 25 °C. They were 
catalase and oxidase positive and resistant to 
cephalothin. H ippura te  hydrolysis, D N A  hydro­
lysis and a rapid H 2S test were perform ed accord­
ing to Lior and Patel (12, 13). T he  biotypes and 
serotypes were determ ined as described p re ­
viously (12,14).
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Antimicrobial susceptibility patterns were de te r­
mined by an agar dilution m ethod (15). Strains 
were tested in M ueller-Hinton agar supple­
m ented with 5 % lysed horse blood and incubated 
for 48 hours in an atm osphere  of 5 % O 2 , 10 % 
C O 2 and 85 % N 2.
D iscussion . In this paper  three  hypogam m a­
globulinémie males with recurrent Cam pylobac­
ter jejuni septicemia and cellulitis are described. 
N one of the patients complained of diarrhoea re­
lated to the episodes of Campylobacter jejuni sep­
ticemia. Fever was usually present during sep­
ticemia, varying between self-limiting bouts and 
persistent low grade fever type. In patient C an 
afebrile episode of bacteremia was recorded.
The incidence of Campylobacter jejuni sep­
ticemia in hypogammaglobulinémie patients is 
probably underestimated. In a review of infec­
tions in 96 hypogammaglobulinémie patients, 
Campylobacter  septicemia was reported  to have 
occurred only once (20). In this case Cam pylobac­
ter fetus was probably the causative organism 
(21). However, among 41 hypogammaglobu-
Figure 1: Skin lesion on the right hand of patient A.
linemic patients under the care of our  team, five 
patients have experienced at least one episode of 
docum ented Campylobacter jejuni septicemia.
Skin lesions due to Campylobacter jejuni have 
been reported  before (9, 10). However, an a t­
tem pt to isolate Campylobacter jejuni from a skin 
aspirate was unsuccessful (9). In patient A  we cul­
tured Campylobacter jejuni from biopsy speci­
mens, and bacteria were seen on electron micros­
copy. These observations strongly suggest m etas­
tatic cellulitis, although microaspiration of blood 
with the biopsy cannot be fully excluded. Since 
our morphological findings indicated that the 
num ber of Campylobacter jejuni in these skin 
lesions was low, the pathogenesis may also have 
been toxin-mediated.
The association of fever, pain localized to the 
lower legs, scintigraphy findings and Cam pylo­
bacter jejuni septicemia in one patient suggests 
that this microorganism may cause osteomyelitis. 
The rapid response of the patient to trea tm ent 
directed against Campylobacter jejuni, including 
normalisation of the findings on I n - l l l - I g G  scin­
tigraphy, which in our experience is a sensitive 
and specific m ethod for detection of bone inflam­
mation (18, 19), is in accordance with this. Be­
cause of the rapid response to therapy no biopsy 
was performed to confirm the diagnosis of osteo­
myelitis. To the best of our  knowledge osteo­
myelitis probably caused by Campylobacter jejuni 
has been reported  only once before (22). In that 
case report no mention was made of serum im­
munoglobulin concentrations.
The results of typing of Campylobacter jejuni iso­
lates in our patients indicate endogenous relapses 
rather than exogenous reinfections. It would ap­
pear to be difficult to eradicate Campylobacter  
jejuni in hypogammaglobulinémie patients. 
The susceptibility of hypogammaglobulinémie 
patients to infection with Campylobacter jejuni is 
probably related to a lack of bactericidal activity 
of hypogammaglobulinémie serum against Cam­
pylobacter jejuni (6, 7, 23, 24), which is not re­
stored by administration of IgG preparations (7, 
24). The importance of humoral immunity in the 
response to Campylobacter jejuni infections has 
also been recognised in patients with A ID S 
presenting with persistent Campylobacter jejuni 
septicemia (25). The results of in vitro studies 
strongly suggest that serum sensitivity of Cam ­
pylobacter jejuni is com plem ent and IgM depend­
ent (23). Previously we have found that plasma 
substitution therapy restores the bactericidal ac­
tivity, indicating a role of IgM (24). We decided to
; S •
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treat patients A  and C with plasma infusions. A 
rise in the IgM level was noted in patient A (Table 
1); neither before nor during plasma infusion 
therapy were detectable levels of IgM found in 
patient C (Table 1). A  high rate of IgM turnover 
at the infectious foci in this patient could explain 
this observation.
Im ipenem  was chosen for therapy in patients A 
and C for several reasons. In patient A  we had 
seen failure of erythromycin which may have 
been caused by rapid development of resistance. 
D evelopm ent of ciprofloxacin resistance in Cam­
pylobacter jejuni has also been reported  (24, 26). 
Furtherm ore, trea tm ent with imipenem, to which 
Campylobacter jejuni is highly sensitive (M IC 90
< 0.125 mg/1), and plasma was the only treatm ent 
which was successful in a previously reported 
patient who suffered from a longstanding Cam­
pylobacter jejuni infection (24). Several trea t­
ment attempts had failed in that patient but after 
trea tm ent with imipenem and plasma the patient 
has been free of Campylobacter jejuni for more 
than four years now. Although the follow-up 
period in patients A  and C is rather short, their 
rapid and good response to treatm ent with im­
ipenem and plasma infusions emphasises the 
value of this regimen when previous antibiotic 
trea tm ent is without success.
We conclude that the diagnosis of Campylobacter  
jejuni septicemia should be considered in hypo­
gammaglobulinémie patients with recurrent 
fever, especially when erysipelas-like skin lesions 
occur. In patients not rapidly responding to 
erythromycin, combination therapy with im­
ipenem and plasma infusions should be con­
sidered in view of the success of this therapy in 
our patients.
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Prosthetic Joint Infection due to 
Candida parapsilosis in the UK: 
Case Report and Literature Review
J. Paul1, S.H. W hite2, K .M . N icholls1, 
D.W . C ro o k 1*
Candida infection o f joint replacements is a rare 
but increasingly reported phenomenon. A case of 
C andida  parapsilo s is  prosthetic knee joint infec­
tion occurring in the UK is described. Cure fol­
lowed removal of the prosthesis and treatment, 
first with a combination of amphotericin and 5- 
fluorocytosine, then ketoconazole.
The overwhelming majority of cases of infection 
of total joint arthroplasties are ascribed to bac­
terial pathogens (1). However, there  is a growing 
N orth  A m erican literature referring to cases of 
prosthetic joint candidosis. A  favourable out­
come of these infections is seen after removal of 
the prosthesis and administration of specific anti- 
fungal treatm ent. However, such successful trea t­
ment depends on isolating Candida  and recognis­
ing it as the aetiologic agent. We describe a case in
P u b l i c  Health Laboratory, Levels 6/7, John Radcliffe 
Hospital, Oxford 0 X 3  9 D U , UK.
2 Nuffield Orthopaedic Centre, Windmill Road, Heading- 
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the U K  of infection of a total knee arthroplasty 
with Candida parapsilosis where our culture- 
based diagnosis was supported by histological 
and serological evidence, and where serial 
serological tests for Candida allowed monitoring 
of the therapeutic  response. The  literature on 
Candida joint infection, its diagnosis and trea t­
ment is reviewed.
Case Report. A  63-year-old man underw ent a 
bicompartmental Oxford knee replacem ent for 
severe osteoarthritis. Continued pain led to 
revision to an Insall Burstein total condylar re ­
placement 20 months later. Loosening of the 
prosthesis but no evidence of infection was noted 
at the time of the revision. T hree  months after 
revision, the joint became hot and red suggesting 
infection. Exploration showed inflamed granula­
tions, but routine microbiological cultures were 
negative. Four months later persistent pain 
resulted in removal of all foreign material and the 
knee was fused using compressive biplanar exter­
nal fixation. Tissue was taken for histological and 
microbiological investigation.
Culture of debrided cancellous bone, joint cap­
sule and periarticular tissue revealed Candida 
parapsilosis in pure growth. Histological ex­
amination of debrided bone showed yeasts and 
chronic, non-specific inflammatory changes. Sera 
taken 8 and 105 days before the time of removal 
of the prosthesis were sent to the Central Public 
Health  Laboratory, London, UK, to test for the 
presence of candidal precipitins and agglutinins. 
The results proved to be highly supportive of a 
diagnosis of infection with Candida parapsilosis. 
A  culture of the organism sent to the Central 
Public Health  Laboratory, London, was found to 
be sensitive to amphotericin, 5-fluorocytosine 
and ketaconazole and the identification was con­
firmed as Candida parapsilosis. O ne week after 
removal of the prosthesis, trea tm ent with in­
travenous amphotericin, 50 mg daily, and 5- 
fluorocytosine, 2500 mg 6-hourly, was started. 
This regimen was well to lerated and continued 
for 40 days, and was followed by trea tm ent for 24 
days with ketoconazole, 200 mg 12-hourly. The 
knee became painless and results of serial 
serological tests for Candida indicated a ther­
apeutic response. A t follow-up two years after 
removal of the prosthesis, the pa tien t’s fused knee 
was trouble-free and serological tests for Candida 
were negative.
Discussion . Fourteen  cases of prosthetic joint 
candidosis including our own case have been 
reported  in the world literature. A part  from the
